Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Hoffman

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Neurology Research International|March 2, 2026
The Amyotrophic Lateral Sclerosis House Call Program: A Single-Center Experience in the United StatesErica Scirocco, Jennifer Scalia, Benedetta Ugolini, et al.
Blood|March 6, 2002
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasiaSteven M Devine, Ron Hoffman, Amit Verma, et al.
Frontiers in Psychiatry|February 21, 2020
The interRAI Suite of Mental Health Assessment Instruments: An Integrated System for the Continuum of CareJohn P Hirdes, Coline van Everdingen, Jason Ferris, et al.
BMC Medical Research Methodology|August 8, 2025
Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignanciesGita Thanarajasingam, Vishal Bhatnagar, Brie N Noble, et al.
American Journal of Hematology|October 6, 2015
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemiaYishai Ofran, Ronit Leiba, Chezi Ganzel, et al.
Blood Advances|November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a studyTsila Zuckerman, Ron Ram, Luiza Akria, et al.
American Journal of Hematology|October 9, 2019
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective studyYishai Ofran, Michal Hayun, Ronit Leiba, et al.
European Journal of Haematology|February 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS OnsetHazim Khatib, Amit Parizat, Jabour Halloun, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Neurology Research International|March 2, 2026
The Amyotrophic Lateral Sclerosis House Call Program: A Single-Center Experience in the United StatesErica Scirocco, Jennifer Scalia, Benedetta Ugolini, et al.
Blood|March 6, 2002
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasiaSteven M Devine, Ron Hoffman, Amit Verma, et al.
Frontiers in Psychiatry|February 21, 2020
The interRAI Suite of Mental Health Assessment Instruments: An Integrated System for the Continuum of CareJohn P Hirdes, Coline van Everdingen, Jason Ferris, et al.
BMC Medical Research Methodology|August 8, 2025
Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignanciesGita Thanarajasingam, Vishal Bhatnagar, Brie N Noble, et al.
American Journal of Hematology|October 6, 2015
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemiaYishai Ofran, Ronit Leiba, Chezi Ganzel, et al.
Blood Advances|November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a studyTsila Zuckerman, Ron Ram, Luiza Akria, et al.
American Journal of Hematology|October 9, 2019
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective studyYishai Ofran, Michal Hayun, Ronit Leiba, et al.
European Journal of Haematology|February 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS OnsetHazim Khatib, Amit Parizat, Jabour Halloun, et al.
Pageof 5